On 11 February 2025, the Commission unveiled its 2025 work program, titled “Moving forward together: A Bolder, Simpler, Faster Union.” This annual document sets out upcoming legislative and policy ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

As U.S. antitrust counsel to global companies, it is increasingly important to track major developments in the international ...

"Our new fiscal 2025 guidance provides for limited further earnings contribution from China, and assumes a continuation of the macro trends we see today," said Ankur Dhingra, CFO of Illumina. "We will ...

La empresa local de secuenciación genética citó ahorros de costos para alinearse con su futura estrategia comercial.

AbbVie, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, and Illumina are the five Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks represent ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

October 28, 2022 EU renews order for Illumina to keep Grail as separate entity EU antitrust regulators on Friday renewed interim measures ordering U.S. life sciences company Illumina to keep Grail ...

CRE Debt and Equity specialists, MaxCap Group MaxCap Group, a strategic investment partner of Apollo, is a leading Australian Commercial Real Estate Debt investment manager. With $7 billion Funds ...

We recently compiled a list of the Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In. In this article, we are going to take a look at where GRAIL, Inc.

HSBC downgraded shares of Illumina (NASDAQ:ILMN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday morning, Ratings reports. The brokerage currently has ...